In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hamilton Pharmaceuticals Inc.

Division of Neuren Pharmaceuticals Ltd.

Latest From Hamilton Pharmaceuticals Inc.

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q3 2007

In this issue, we present another installment of our quarterly review of pharmaceutical/biotechnology dealmaking-for July-September 2007. Our data come from Windhover's Strategic Transactions Database.

The A-List: 2005's Trend-Shaping Series A Financings

2005's top early stage venture financings reflect a drive for size and experience on the biotech side, and the demand for less-invasive procedures in the device world. Start-Up lists the top ten Series A rounds of 2005.
BioPharmaceutical Medical Device

Hamilton Pharmaceuticals Inc.

Thomas N. Chase, MD, had a prolific career as an investigator at the National Institutes of Neurological Disorders and Stroke. Now at specialty pharma start-up Hamilton Pharmaceuticals Inc., Chase plans to build a pipeline of drugs for a full spectrum of CNS disorders, including stroke, Parkinson's disease, epilepsy, multiple sclerosis and schizophrenia.

Start-Up Previews (6/05)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, New Drugs for Myocardial Infarction, features profiles of ArgiNOx Pharmaceuticals, ParinGenix and VasoGenix Pharmaceuticals. Plus these Start-Ups Across Health Care: AngioScore, Hamilton Pharmaceuticals, Ikaria, Light BioScience and Potentia Pharmaceuticals.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Neuren Pharmaceuticals Ltd.
  • Senior Management
  • Thomas N Chase, MD, CEO
    Tom Roy, Dir., Fin.
  • Contact Info
  • Hamilton Pharmaceuticals Inc.
    Phone: (202) 223-7001
    1825 K St. NW
    Ste. 520
    Washington, DC 20006